They already fixed it the free market way by ousting the CEO. The majority shareholder is German. Beyond that they can just invoke national emergency and take

They already fixed it the free market way by ousting the CEO. The majority shareholder is German. Beyond that they can just invoke national emergency and take control if it was needed. The company works with Paul Ehrlich institute which means tax payer subsidies and ironclad contracts and regulation. This isn't Deutsche Bank paying for Trumps Russian deals - German medical science is very well integrated and protected.